GlassScriptPhysician profile
Stephen T Thew
NPI 1588617591
$2,233.81
in general payments reported to CMS, 2019-2025
19 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $46.41 · 2021: $172 · 2022: $234 · 2023: $74.91 · 2024: $663 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,228.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $641.22 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Rotapro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.94 | 2019-2024 | Jardiance |
| Pfizer INC. | $164.43 | 2019-2025 | |
| Amgen INC. | $155.35 | 2020-2025 | Repatha |
| Edwards Lifesciences Corporation | $146.91 | 2019-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $140.60 | 2019 | |
| Atricure, INC. | $120.64 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $102.01 | 2022-2025 | Farxiga |
| Abiomed | $90.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $85.18 | 2024-2025 | Camzyos |
| Philips North America LLC | $83.15 | 2024-2025 | (P77) Azurion 7 M20, Mcot |
| Janssen Pharmaceuticals, INC | $42.44 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $42.03 | 2019 | |
| Medtronic Vascular, INC. | $34.79 | 2019 | |
| Heartflow, INC. | $23.90 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $16.39 | 2019 | |
| Merck Sharp & Dohme LLC | $16.20 | 2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $15.69 | 2024 | |
| Terumo Medical Corporation | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Thew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.